레파넘정0.5밀리그램(레파글리니드)
Recall Summary Repanan 0.5mg (Repaglinide), a diabetes medication distributed in South Korea by Darim Biotech, is being recalled due to excessive levels of an impurity called N-nitroso-melumine found in distributed products. The recall affects three specific product batches identified by their barcodes. This is classified as a Class II recall.
- Recalling firm
- (주)다림바이오텍
- Product
- 레파넘정0.5밀리그램(레파글리니드) (Barcode: 8806646020400, 8806646020417, 8806646020424)
- Reason
- 불순물(N-nitroso-melumine)초과검출에따른시중유통품에대한영업자회수
- Classification
- Class II
- Category
- drug recall
- Country
- South Korea
- Agency
- MFDS-DRUG
- Recall date
- 2026-08-19
- Status
- Ongoing
- Distribution
- South Korea
Official recall notice from MFDS-DRUG
Recall details on Nibble Recalls: https://trynibble.app/recalls/423df7d7-1c64-4bf7-beb3-9ebe03819662